References
- Yusuf S, Ounpuu S, Anand A. Global burden of cardiovascular diseases: part 1 general considerations, the epidemiologic transition, risk factors and impact of urbanization. Circulation 2001;104:2746–53.
- Silva-Herdade A, Saldanha C. Hemorheological effects of valsartan in L-NAME induced hypertension in rats. Open Circul Vasc J 2011;4:1–5.
- Gerald W, Dryden Ion D, Gavin A, Craig J. McClain clinical implications of oxidative stress and antioxidant therapy. Cur Gastroenterol Rep 2005;7:308–16.
- Maxwell SR. Prospects for the use of antioxidant therapies. Drugs 1995;49:345–61.
- Getz GS, Reardon CA. Nutrition and cardiovascular disease. Arterioscler Thromb Vasc Biol 2007;27:2499–506.
- Retelny VS, Neuendorf A, Roth JL. Nutrition protocols for the prevention of cardiovascular disease. Nutr Clin Pract 2008;23:468–76.
- Civolani C, Barghini P, Roncetti AR, Ruzzi M, Schiesser A. Bioconversion of ferulic acid into vanillic acid by means of a vanillate-negative mutant of Pseudomonas fluorescens strain BF13. Appl Environ Microbiol 2000;66:2311–17.
- Duke JA. Handbook of phytochemical constituents of GRAS herbs and other economic plants. Boca Raton: CRC Press; 1992.
- Varma RS, Shukla A, Chatterjee RK. Evaluation of vanillic acid analogues as a new class of antifilarial agents. Indian J Exp Biol 1993;31:819–21.
- Rai RP, Maurya MS. Synthesis and evaluation of antibacterial activity of vanillin derivatives. J Sci Tech 1966;4:275–6.
- Delaquis P, Stanich K, Toivonen P. Effect of pH on the inhibition of Listeria spp. by vanillin and vanillic acid. J Food Protec 2005;68:1472–6.
- Stanely Mainzen Prince P, Dhanasekar K, Rajakumar S. Preventive effects of Vanillic acid on lipids, Bax, Bcl-2 and myocardial infarct size on isoproterenol-induced myocardial infarcted rats: a biochemical and in vitro study. Cardiovasc Toxicol 2011;11:58–66.
- Tsuda H, Uehara N, Iwahori Y, Asamoto M, Ligo M, Nagao M, et al. Chemopreventive effects of beta-carotene, alpha-tocopherol and five naturally occurring antioxidants on initiation of hepatocarcinogenesis by 2-amino-3-methylimidazo [4, 5] quinoline in the rat. Japanese J Cancer Res 1994;85:1214–9.
- Raja B, Deepa Mol S. The protective role of vanillic acid against acetaminophen induced hepatotoxicity in rats. J Pharm Res 2010;3:1480–4.
- Afkir S, Benoit Nguelefack T, Aziz M, Zoheir J, Cuisinaud G, Bnouham M, et al. Arbutus unedo prevents cardiovascular and morphological alterations in L-NAME-induced hypertensive rats Part I: cardiovascular and renal hemodynamic effects of Arbutus unedo in L-NAME-induced hypertensive rats. J Ethnopharmacol 2008;116:288–95.
- Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrite and nitrate in biological fluids. Anal Biochem 1982;126:131–8.
- Niehaus WG, Samuelson B. Formation of malondialdehyde from phospholipid arachidonate during microsomal lipid peroxidation. Eur J Pharmacol 1968;6:126–30.
- Jiang ZY, Hunt JV, Wolff SP. Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein. Anal Biochem 1992;202:384–9.
- Rao KS, Recknagel RO. Early onset of lipid peroxidation in rat liver after carbon tetrachloride administration. Exp Mol Pathol 1968;9:271–8.
- Kakkar P, Das B, Viswanathan PN. A modified spectrophotometric assay of superoxide dismutase. Ind J Biochem Biophys 1984;21:130–2.
- Sinha KA. Colorimetric assay of catalase. Anal Biochem 1972;47:389–94.
- Rotruck JT, Pop AL, Ganther H, Hafeman BG, Hoeksira WG. Selenium: biochemical role as a component of glutathione peroxides. Science 1973;179:588–90.
- Baker H, Frank O, De Angelis B, Feingold S. Plasma tocopherol in man at various times after ingesting free or acetylated tocopherol. Nutr Rep Int 1980;21:531–6.
- Ellman GL. Tissue sulphydryl groups. Arch Biochem Biophys 1959;82:70–7.
- Katsumi H, Nishikawa M, Hashida H. Development of nitric oxide donors for the treatment of cardiovascular diseases. Cardiovasc Hematol Agents Med Chem 2007;5:204–8.
- Ribeiro MO, Antunes E, De Nucci G, Lovisolo SM, Zatz R. Chronic inhibition of nitric oxide synthase, a new model of arterial hypertension. Hypertension 1992;20:298–303.
- Jover B, Herizi A, Ventre F, Dupont M, Mimran A. Sodium and angiotension in hypertension induced by long-term nitric oxide blockade. Hypertension 1993;21:944–8.
- Baylis C, Mitruka B, Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glumerular damage. J Clin Invest 1992;90:278–81.
- Ulker S, McKeown PP, Bayraktutan U. Vitamins Reverse endothelial dysfunction through regulation of eNOS and NAD(P)H oxidase activities. Hypertension 2003;41:534–9.
- Fridovich I. The biology of oxygen radicals. Science 1978;201:875–80.
- Frank L, Massaro D. Oxygen toxicity. Am J Med 1980;69:117–26.
- Kumar S, Saravana Kumar M, Raja B. Efficacy of piperine, an alkaloidal constituent of pepper on nitric oxide, antioxidants and lipid peroxidation markers in L-NAME induced hypertensive rats. Int J Res Pharm Sci 2010;3:300–7.
- Halliwell B, Chirico S. Lipid peroxidation: its mechanism, measurement, and significance. Am J Clin Nutr 2005;57:715–24.
- Hamberg M, Svensson J, Wakabayashi T, Samuelsson B. Isolation and structure of two prostaglandins endoperoxides that cause platelet aggregation. Proc Natl Acad Sci 1974;71:345–59.
- Roy AKD, Gordon MJ, Campbell FM, Duthie GG, James WPT. Vitamin-E requirement, transport and metabolism: role of α-tocopherol-binding protein. J Nutr Biochem 1994;5:562–70.
- Karthikeyan J, Rani P. Enzymatic and non enzymatic antioxidants in selected piper speice. Ind J Exp Biol 2003;41:135–40.
- Abidi P, Afaq F, Arif JM, Lohani M, Rahman Q. Chrysotilemediated imbalance in the glutathione redox system in the development of pulmonary injury. Toxicol Lett 1999;106:31–9.
- Dey A, Cederbaum AI. Alcohol and oxidative liver injury. Hepatology 2006;43:63–74.
- Hoetzel A, Welle A, Schmidt R, Loop T, Humar M, Ryter SW, et al. Nitric oxide-deficiency regulates hepatic heme oxygenase-1. Nitric Oxide Biol Chem 2008;18:61–9.
- Loria P, Lonardo A, Carulli L, Verrone AM, Ricchi M, Lombardini S, et al. The metabolic syndrome and non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2005;22:31–6.
- Bech JN, Nielsen CB, Ivarsen P, Jensen KT, Pedersen EB. Dietary sodium affects systemic and renal hemodynamic response to NO inhibition in healthy humans. Am Physiol 1998;274:914–23.
- Burtis CA, Ashwood ER. Enzymes, Teitz fundamentals of clinical chemistry. 4th ed. Philadelphia, USA: NB Saunders Company; 1996. p. 312–35.